NasdaqGS:PODDMedical Equipment
Insulet (PODD) TTM Margin Drop To 9.8% Tests Bullish Growth Narratives
Insulet (PODD) just put up third quarter FY 2025 numbers with revenue of US$706.3 million and basic EPS of US$1.24, alongside net income of US$87.6 million, setting the tone for how the rest of the year is shaping up. The company has seen revenue move from US$488.5 million in Q2 2024 to US$649.1 million in Q2 2025 and US$706.3 million in Q3 2025, while basic EPS shifted from US$2.69 to US$0.32 and then US$1.24 over the same quarters. This gives investors a clear view of how the top line and...